ArticleMolecular therapy. Methods & clinical development2016

RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelope.

Virna Marin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.